earnings
DN
NASDAQ · DNLI
Denali Therapeutics Inc.
Healthcare · Biotechnology
$24.92
Down-$0.03 (-0.12%)
Updated Aug 22, 2026, 10:09 AM
SID Score
6.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.55B
- P/E ratio
- -6
- Dividend yield
- 0.00%
- 52-week range
- $12.58 – $27.30
- Volume
- 680.99K
- Avg. volume
- 1.72M
Price performance
DNLI price history
1M range · 21 trading sessions · Daily adjusted prices
DNLI closed at $24.92 after 21 trading sessions, up 7.83% for the selected period.
- Last close
- $24.92
- Period change
- +7.83%
- Period low
- $23.02
- Period high
- $25.69
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $25.25 | $25.37 | $24.60 | $24.92 | 680.99K |
| Aug 20, 2026 | $25.15 | $25.6031 | $24.65 | $24.95 | 976.85K |
| Aug 19, 2026 | $25.00 | $25.70 | $24.61 | $25.69 | 1.15M |
| Aug 18, 2026 | $24.17 | $24.49 | $24.01 | $24.31 | 1.1M |
| Aug 17, 2026 | $24.29 | $24.66 | $24.11 | $24.35 | 1M |
| Aug 14, 2026 | $24.53 | $24.62 | $24.115 | $24.40 | 890K |
| Aug 13, 2026 | $25.24 | $25.64 | $24.81 | $24.82 | 1.35M |
| Aug 12, 2026 | $24.51 | $25.34 | $24.20 | $25.27 | 1.44M |
| Aug 11, 2026 | $25.07 | $25.29 | $24.59 | $24.69 | 1.15M |
| Aug 10, 2026 | $24.71 | $25.035 | $24.21 | $25.00 | 1.56M |
| Aug 7, 2026 | $25.41 | $25.74 | $24.235 | $24.83 | 1.75M |
| Aug 6, 2026 | $24.48 | $24.99 | $24.37 | $24.73 | 3.05M |
| Aug 5, 2026 | $24.29 | $24.55 | $23.96 | $24.42 | 1.09M |
| Aug 4, 2026 | $23.55 | $24.30 | $23.23 | $24.17 | 993.77K |
| Aug 3, 2026 | $22.85 | $23.50 | $22.6275 | $23.15 | 1.48M |
| Jul 31, 2026 | $24.34 | $24.35 | $22.99 | $23.02 | 1.23M |
| Jul 30, 2026 | $23.83 | $24.68 | $23.785 | $24.35 | 1.12M |
| Jul 29, 2026 | $24.20 | $24.3864 | $23.61 | $23.85 | 1.38M |
| Jul 28, 2026 | $23.92 | $24.055 | $23.15 | $24.05 | 2.11M |
| Jul 27, 2026 | $23.59 | $24.17 | $23.44 | $23.57 | 1.75M |
| Jul 24, 2026 | $23.52 | $23.65 | $22.64 | $23.11 | 1.16M |
Latest DNLI news
The latest Smart Investors Daily articles mentioning DNLI.
Stock researchResearch & News · Competitors
Loading stock research…